Related Experiment Video
Updated: Jul 11, 2026
Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
Published on: August 24, 2019
Cardiovascular risk in chronic obstructive pulmonary disease
John D Maclay1, David A McAllister, William Macnee
1Centre for Inflammation Research, University of Edinburgh, Edinburgh, UK.
Insights
Chronic obstructive pulmonary disease (COPD) significantly increases cardiovascular disease (CVD) risk, independent of traditional factors. This review explores the
Area of Science:
- Cardiology
- Pulmonology
- Public Health
Background:
- Cardiovascular disease (CVD) is a major cause of death in patients with chronic obstructive pulmonary disease (COPD).
- Traditional CVD risk factors like smoking and sedentary behavior are common in COPD patients.
- Emerging evidence indicates airflow limitation itself is an independent CVD risk factor.
Purpose of the Study:
- To review the association between COPD and CVD.
- To examine systemic factors in COPD contributing to CVD pathogenesis.
- To discuss therapeutic interventions for modifying cardiovascular risk in COPD.
Main Methods:
- Literature review of studies on CVD in COPD.
- Analysis of systemic factors (inflammation, oxidative stress, hypoxia) in COPD.
- Evaluation of studies on interventions targeting cardiovascular risk in COPD.
Main Results:
- COPD is an independent risk factor for CVD, suggesting a 'COPD effect'.
- Systemic inflammation, oxidative stress, and hypoxia in COPD contribute to atherosclerosis.
- Therapeutic interventions may mitigate cardiovascular risk in COPD patients.
Conclusions:
- COPD has significant systemic consequences beyond lung pathology, increasing CVD risk.
- Understanding the 'COPD effect' is crucial for comprehensive patient management.
- Further research into interventions is needed to reduce CVD morbidity and mortality in COPD.
Abstract:
Cardiovascular disease (CVD) contributes significantly to morbidity and mortality in COPD. There is a high prevalence of traditional risk factors in this patient group including smoking, sedentary behaviour and low socio-economic class. However, large studies have shown that airflow limitation is an independent risk factor for CVD. Therefore there may be a 'COPD effect' that contributes to CVD in this condition, adding to the body of evidence that COPD has important systemic consequences, as well as being a lung disease. In this article, we review the evidence for CVD in COPD. Next, we examine systemic factors present in COPD, and link these to the pathogenesis of atherosclerosis, including inflammation, oxidative stress and hypoxia. Finally, we review those studies that have investigated therapeutic interventions in COPD that may modify cardiovascular risk.
Related Concept Videos
01:24Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
01:23Chronic Obstructive Pulmonary Disease I: Introduction
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
01:29Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation